Salvi, S
Casadio, V
Conteduca, V
Burgio, S L
Menna, C
Bianchi, E
Rossi, L
Carretta, E
Masini, C
Amadori, D
Calistri, D
Attard, G
De Giorgi, U
Article History
Received: 8 January 2015
Revised: 24 February 2015
Accepted: 7 March 2015
First Online: 21 April 2015
Competing interests
: UG and VC received speaker honorarium from Janssen-Cilag. The ICR developed abiraterone and therefore has a commercial interest in this agent. GA is on the ICR list of rewards to inventors for abiraterone. GA has received honoraria, consulting fees or travel support from Astellas, Medivation, Janssen, and grant support from Janssen.